Biotech

All Articles

Vaxcyte rises on 'stunning' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what experts referred to as "stunning" phase 1/2 information for its 31-valent pne...

Recursion's human brain condition test reveals insufficient evidence of effectiveness

.Recursion has actually stumbled through a very early examination of its own tech-enabled strategy t...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Phone it a case of really good chemistry: Acepodia, a biotech based on Nobel Champion science, is a...

Praxis epilepsy drug decreases confiscations in phase 2 hearing

.Practice Precision Medicines has racked up one more midphase win in epilepsy this year, along with ...

Three execs resign as Dyne articles blended data for DMD candidate

.After getting away a clinical grip a number of years back, Dyne Therapy has actually disclosed bran...

Arrowhead fires off phase 3 records in uncommon metabolic health condition before market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its give ahead of a potential showdown with Ionis, rel...

Pfizer, Valneva present lyme illness try efficient for 2nd booster

.Pfizer as well as Valneva may possess concerning 2 even more years to hang around before they help ...

Fierce Biotech Managing Editor Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Let's study a discussion along with Ayla Ellison, Fierce Biotech Editor-in-Chief and also Michelle ...

New records show how Bayer's asundexian fell short to avoid movements

.Bayer suspended the phase 3 test for its own element XIa inhibitor asundexian behind time in 2013 a...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA, execs ha...